This webinar will show the latest indications for the medical treatment of metastatic renal cell carcinoma (RCC) according to the evidence showed in literature and at the ASCO GU 2023 congress. Lectures will highlight the first-line and second-line treatment in this stage of the disease. The last part of the webinar will focus on the clinical management of adverse events following systemic treatment in metastatic RCC.
